Equibles does not estimate personal net worth.
Get an email with a short summary when Zimmer Biomet Holdings, Inc. publishes a filing, an earnings call transcript or a press release.
Get ZBH alertsSuketu Upadhyay is recorded as CFO at Zimmer Biomet Holdings, Inc. (ZBH) since August 22, 2023. Zimmer Biomet Holdings, Inc. reported in an 8-K filed April 28, 2026 that Suketu Upadhyay resigned as Chief Financial Officer and Executive Vice President – Finance, Operations and Supply Chain, effective April 28, 2026. Zimmer Biomet Holdings, Inc. reported in an 8-K filed August 22, 2023 that Suketu Upadhyay was appointed Chief Financial Officer and Executive Vice President – Finance, Operations and Supply Chain, effective August 22, 2023. The proxy statement of Zimmer Biomet Holdings, Inc. reports total compensation of $6,211,805 for Suketu Upadhyay in fiscal 2025, including a base salary of $906,780. Disclosed compensation is on record for 7 fiscal years. Suketu Upadhyay has spoken on 8 earnings calls across 1 company, most recently for Zimmer Biomet Holdings, Inc. on April 28, 2026. Zimmer Biomet Holdings, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Zimmer Biomet Holdings, Inc. includes Daniel Florin (CEO), Ivan Tornos (CEO, Chairman and Board Member), Christopher B. Begley (Chairman) and 7 others.
“On April 22, 2026, Suketu Upadhyay informed Zimmer Biomet Holdings, Inc. (the "Company") of his intention to resign from the position of Chief Financial Officer and Executive Vice President – Finance, Operations and Supply Chain of the Company, effective as of April 28, 2026, to pursue a new professional opportunity.”
“Additionally, effective August 22, 2023, Suketu Upadhyay has been appointed to the newly-created position of Chief Financial Officer and Executive Vice President – Finance, Operations and Supply Chain.”
“I'm proud of what we've accomplished together over the past seven years. I believe Zimmer Biomet has a clear strategy and meaningful opportunity ahead.”
“This quarter, we grew sales 5% on an organic constant currency basis and delivered adjusted earnings per share of $1.90, which was up 9.2% year-over-year despite dilution from the Paragon 28 transaction, the impact of tariffs, and continued investments in our commercial organization.”
“As Ivan mentioned, we closed another solid year demonstrating the resilience and winning attitude of our team members.”
“As Ivan mentioned, we closed another solid quarter, showcasing the resilience and winning attitude across our nearly 18,000 team members. Despite ERP-related headwinds, we grew sales over 4%, while maintaining steady operating margins, generating $1.74 in adjusted earnings per share, and $310 million in free cash flow.”
“As Ivan mentioned, we had another good quarter driven by healthy end markets and solid execution across the organization.”
2023-08-22–present
2023-08-22–2026-04-28
Start not stated–2026-04-28
Medical Devices · Healthcare
CFO
2023-08-22–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Zimmer Biomet Holdings, Inc. (ZBH) | CFO and EVP - Finance, Operations and Supply Chain | $906,780 | $6,211,805 |
| 2024 | Zimmer Biomet Holdings, Inc. (ZBH) | CFO and EVP - Finance, Operations and Supply Chain | $876,154 | $5,879,562 |
| 2023 | Zimmer Biomet Holdings, Inc. (ZBH) | CFO and EVP - Finance, Operations and Supply Chain | $801,839 | $10,384,929 |
| 2022 | Zimmer Biomet Holdings, Inc. (ZBH) | CFO and EVP - Finance, Operations and Supply Chain | $753,080 | $5,523,318 |
| 2021 | Zimmer Biomet Holdings, Inc. (ZBH) | CFO and EVP - Finance, Operations and Supply Chain | $663,431 | $4,616,214 |
| 2020 | Zimmer Biomet Holdings, Inc. (ZBH) | Executive VP, CFO | $690,577 | $3,894,183 |
| 2019 | Zimmer Biomet Holdings, Inc. (ZBH) | Executive VP, CFO | $337,500 | $6,080,250 |
